Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


09.10.2017

1 Adv Exp Med Biol
1 Am J Cancer Res
1 Am J Clin Pathol
2 Anticancer Res
1 Br J Cancer
1 Br J Oral Maxillofac Surg
1 Cancer Discov
1 Cell Mol Biol (Noisy-le-grand)
1 Cell Physiol Biochem
1 Chem Biodivers
1 Curr Opin Urol
1 Eur J Cancer Care (Engl)
1 Eur J Oncol Nurs
1 Eur Urol
1 Exp Ther Med
1 Genomics
1 Int J Occup Environ Med
2 J Natl Compr Canc Netw
1 J Vasc Surg
1 Jpn J Clin Oncol
2 Minerva Urol Nefrol
1 Mol Cancer Res
1 Nat Rev Urol
1 Obstet Gynecol
13 Oncotarget
1 Photochem Photobiol Sci
1 Proteomics Clin Appl
1 Radiother Oncol
1 Sci Rep
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Exp Med Biol

  1. LAVDANITI M, Zyga S
    Quality of Life in Elderly Bladder Cancer Patients Following a Cystectomy.
    Adv Exp Med Biol. 2017;989:297-300.
    PubMed     Text format     Abstract available


    Am J Cancer Res

  2. TILLEY SK, Kim WY, Fry RC
    Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.
    Am J Cancer Res. 2017;7:1850-1862.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  3. FOX MD, Xiao L, Zhang M, Kamat AM, et al
    Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
    Am J Clin Pathol. 2017;147:500-506.
    PubMed     Text format     Abstract available


    Anticancer Res

  4. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics.
    Anticancer Res. 2017;37:5603-5608.
    PubMed     Text format     Abstract available

  5. AIZAWA R, Sakamoto M, Orito N, Kono M, et al
    The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients.
    Anticancer Res. 2017;37:5761-5766.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. MORERA DS, Hennig MS, Talukder A, Lokeshwar SD, et al
    Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
    Br J Cancer. 2017 Oct 3. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  7. HAYAKAWA M, Kodama M, Sato S, Tomoeda-Mori K, et al
    Electrochemical telomerase assay for screening for oral cancer.
    Br J Oral Maxillofac Surg. 2016 Jan 25. pii: S0266-4356(16)00005.
    PubMed     Text format     Abstract available


    Cancer Discov


  8. Targeting Angiogenesis in Bladder Cancer.
    Cancer Discov. 2017 Oct 4. doi: 10.1158/2159-8290.CD-NB2017.
    PubMed     Text format     Abstract available


    Cell Mol Biol (Noisy-le-grand)

  9. PENCE S, Ozbek E, Ozan Tiryakioglu N, Ersoy Tunali N, et al
    rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:46-52.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  10. FAN B, Zhang X, Ma Y, Zhang A, et al
    Fangchinoline Induces Apoptosis, Autophagy and Energetic Impairment in Bladder Cancer.
    Cell Physiol Biochem. 2017;43:1003-1011.
    PubMed     Text format     Abstract available


    Chem Biodivers

  11. RADAN M, Carev I, Tesevic V, Politeo O, et al
    Qualitative HPLC-DAD/ESI-TOF-MS Analysis, Cytotoxic, and Apoptotic Effects of Croatian Endemic Centaurea ragusina L. Aqueous Extracts.
    Chem Biodivers. 2017;14.
    PubMed     Text format     Abstract available


    Curr Opin Urol

  12. SORIA F, Marra G, Capoun O, Soukup V, et al
    Prevention of bladder cancer incidence and recurrence: tobacco use.
    Curr Opin Urol. 2017 Oct 3. doi: 10.1097/MOU.0000000000000453.
    PubMed     Text format     Abstract available


    Eur J Cancer Care (Engl)

  13. SKRZYPCZYK MA, Nyk L, Szostek P, Szemplinski S, et al
    The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection.
    Eur J Cancer Care (Engl). 2017;26.
    PubMed     Text format     Abstract available


    Eur J Oncol Nurs

  14. JENSEN BT, Kiesbye B, Soendergaard I, Jensen JB, et al
    Efficacy of preoperative uro-stoma education on self-efficacy after Radical Cystectomy; secondary outcome of a prospective randomized controlled trial.
    Eur J Oncol Nurs. 2017;28:41-46.
    PubMed     Text format     Abstract available


    Eur Urol

  15. OHNO Y
    Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Eur Urol. 2017 Sep 26. pii: S0302-2838(17)30780.
    PubMed     Text format    


    Exp Ther Med

  16. HE X, Ping J, Wen D
    MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
    Exp Ther Med. 2017;14:3253-3258.
    PubMed     Text format     Abstract available


    Genomics

  17. BAUR B, Bozdag S
    ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
    Genomics. 2017;109.
    PubMed     Text format     Abstract available


    Int J Occup Environ Med

  18. FARZANEH F, Mehrparvar AH, Lotfi MH
    Occupations and the Risk of Bladder Cancer in Yazd Province: A Case-Control Study.
    Int J Occup Environ Med. 2017;8:191-198.
    PubMed     Text format     Abstract available


    J Natl Compr Canc Netw

  19. SPIESS PE, Agarwal N, Bangs R, Boorjian SA, et al
    Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw. 2017;15:1240-1267.
    PubMed     Text format     Abstract available

  20. WARRICK JI
    Clinical Significance of Histologic Variants of Bladder Cancer.
    J Natl Compr Canc Netw. 2017;15:1268-1274.
    PubMed     Text format     Abstract available


    J Vasc Surg

  21. LEEMAN M, Burgers P, Brehm V, van Brussel JP, et al
    Psoas abscess after bacille Calmette-Guerin instillations causing iliac artery contained rupture.
    J Vasc Surg. 2017;66:1236-1238.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  22. TANAKA T, Koie T, Ohyama C, Hashimoto Y, et al
    Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
    Jpn J Clin Oncol. 2017 Aug 18:1-5. doi: 10.1093.
    PubMed     Text format     Abstract available


    Minerva Urol Nefrol

  23. SCHIFFMANN J, Sun M, Gandaglia G, Tian Z, et al
    Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
    Minerva Urol Nefrol. 2017;69:173-180.
    PubMed     Text format     Abstract available

  24. CORONA MONTES VE, Pastore AL, Gausa L, Rodriguez-Faba O, et al
    Robot assisted retroperitoneal lymph-node dissection after adjuvant therapy: different indications.
    Minerva Urol Nefrol. 2017;69:153-158.
    PubMed     Text format     Abstract available


    Mol Cancer Res

  25. DUEX JE, Swain KE, Dancik GM, Paucek RD, et al
    Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer.
    Mol Cancer Res. 2017 Oct 2. pii: molcanres.0260.2017.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  26. THOMA C
    Bladder cancer: Drug sequencing in metastatic disease.
    Nat Rev Urol. 2017 Oct 4. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Obstet Gynecol

  27. SONG M, Glasgow M, Murugan P, Rivard C, et al
    Aggressive Angiomyxoma of the Vulva and Bladder.
    Obstet Gynecol. 2017;130:885-888.
    PubMed     Text format     Abstract available


    Oncotarget

  28. SONG Y, Zhang P, Sun Y, Li X, et al
    AMPK activation-dependent autophagy compromises oleanolic acid-induced cytotoxicity in human bladder cancer cells.
    Oncotarget. 2017;8:67942-67954.
    PubMed     Text format     Abstract available

  29. PICHLER R, Heidegger I, Fritz J, Danzl M, et al
    PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy.
    Oncotarget. 2017;8:66849-66864.
    PubMed     Text format     Abstract available

  30. YUAN D, Zheng S, Wang L, Li J, et al
    MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
    Oncotarget. 2017;8:67663-67669.
    PubMed     Text format     Abstract available

  31. WANG X, Cui MM, Xu Y, Liu L, et al
    Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
    Oncotarget. 2017;8:68115-68122.
    PubMed     Text format     Abstract available

  32. YANG J, Liu Y, He A, Liu Y, et al
    Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.
    Oncotarget. 2017;8:68721-68729.
    PubMed     Text format     Abstract available

  33. LI H, Xu Y, Li H
    CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.
    Oncotarget. 2017;8:62573-62588.
    PubMed     Text format     Abstract available

  34. XIE Y, Li P, Gao Y, Gu L, et al
    Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:62489-62499.
    PubMed     Text format     Abstract available

  35. LIU Q, Diao R, Feng G, Mu X, et al
    Risk score based on three mRNA expression predicts the survival of bladder cancer.
    Oncotarget. 2017;8:61583-61591.
    PubMed     Text format     Abstract available

  36. HUANG Y, Fang C, Shi JW, Wen Y, et al
    Identification of hMex-3A and its effect on human bladder cancer cell proliferation.
    Oncotarget. 2017;8:61215-61225.
    PubMed     Text format     Abstract available

  37. KIM YJ, Byun SJ, Ahn H, Kim CS, et al
    Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Oncotarget. 2017;8:68996-69004.
    PubMed     Text format     Abstract available

  38. HAMANO I, Hatakeyama S, Iwamurau H, Fujita N, et al
    Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017;8:61404-61414.
    PubMed     Text format     Abstract available

  39. BI H, Zhang Z, Guo L, Fu C, et al
    Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
    Oncotarget. 2017;8:63258-63264.
    PubMed     Text format     Abstract available

  40. MONTANO R, Khan N, Hou H, Seigne J, et al
    Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor.
    Oncotarget. 2017;8:67754-67768.
    PubMed     Text format     Abstract available


    Photochem Photobiol Sci

  41. GEDERAAS OA, Johnsson A, Berg K, Manandhar R, et al
    Photochemical internalization in bladder cancer - development of an orthotopic in vivo model.
    Photochem Photobiol Sci. 2017 Oct 3. doi: 10.1039/c7pp00176.
    PubMed     Text format     Abstract available


    Proteomics Clin Appl

  42. LATOSINSKA A, Frantzi M, Vlahou A, Merseburger AS, et al
    Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
    Proteomics Clin Appl. 2017 Oct 5. doi: 10.1002/prca.201700074.
    PubMed     Text format     Abstract available


    Radiother Oncol

  43. WALKER M, French SD, Doiron RC, Brennan K, et al
    Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers.
    Radiother Oncol. 2017 Sep 30. pii: S0167-8140(17)32561.
    PubMed     Text format     Abstract available


    Sci Rep

  44. TERVAHARTIALA M, Taimen P, Mirtti T, Koskinen I, et al
    Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.
    Sci Rep. 2017;7:12682.
    PubMed     Text format     Abstract available


    World J Urol

  45. SORIA F, Shariat SF, Lerner SP, Fritsche HM, et al
    Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
    World J Urol. 2017;35:379-387.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: